Episode 169: How Biomarker Testing Drives the Use of Targeted Therapies

ONS member Cyndy Simonson, MS, APRN-BC, AOCN®, oncology nurse practitioner who is the nursing editor at Duke Regional Hospital in Durham, NC, and member of the North Carolina Triangle ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss biomarker testing for patients with cancer and how it affects targeted therapy regimens during treatment. The advertising messages in this episode are paid for by G1 Therapeutics, Inc. 

Episode Notes

Check out these resources from today’s episode: 

• NCPD contact hours are not available for this episode.
• Oncology Nursing Podcast Episode 134: Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon
• Oncology Nursing Podcast Episode 157: Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung Cancer
• ONS Voice article: Help Patients Understand Genomic Variants of Unknown Significance
• Clinical Journal of Oncology Nursing article: Predictive Biomarkers: Understanding Their Use in Treatment Decision Making
• ONS course: Biomarker Testing in Non-Small Cell Lung Cancer: Optimal Care Coordination Starts With You
• ONS genomics taxonomy
• American Cancer Society information on biomarker testing
• National Cancer Institute information on biomarker testing
• National Comprehensive Cancer Network Biomarkers Compendium
• Research to Practice (Dr. Neil Love’s educational resources)
• 2020 study on adoption and implementation of targeted cancer therapy in community oncology

To discuss the information in this episode with other oncology nurses, visit the ONS Communities.

To provide feedback or otherwise reach ONS about the podcast, email [email protected].